Live Breaking News & Updates on Jonathan Gershoni

Stay updated with breaking news from Jonathan gershoni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Could DNA vaccines be the next tool in the world's battle against COVID? – HotAir

Could DNA vaccines be the next tool in the world's battle against COVID? – HotAir
hotair.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hotair.com Daily Mail and Mail on Sunday newspapers.

Jonathan Gershoni , Tel Aviv University Prof , Tel Aviv University ,

Latest Data Confirms High Effectivity of Pfizer Vaccine


Israel
By Hamodia Staff
YERUSHALAYIM -
A vial of the Pfizer vaccine for COVID-19. (AP Photo/Jessica Hill, File)
The latest batch of data from the Israeli covid vaccination drive has shown the Pfizer vaccine to be 96.7 percent effective at preventing virus-related death, and 97.5% effective against serious illness.
The study was published Wednesday in the leading peer-reviewed medical journal The Lancet.
“In Israel we can see the reality of what vaccines do all around us, but this research is important in quantifying it and documenting it for others around the world to see, and understand the full benefits of vaccines,” Bar Ilan University epidemiologist Prof. Michael Edelstein told The Times of Israel. ....

Israel General , Michael Edelstein , Jonathan Gershoni , Jessica Hill , Drug Administration , Tel Aviv University , Bar Ilan University , Ilan University , இஸ்ரேல் ஜநரல் , மைக்கேல் எடெல்ஸ்டீன் , ஜெசிகா மலை , தொலைபேசி அவிவ் பல்கலைக்கழகம் , மதுக்கூடம் இலன் பல்கலைக்கழகம் , இலன் பல்கலைக்கழகம் ,

Pfizer vaccine 96.7% effective at preventing COVID deaths, Israeli data shows


It is 97% effective in preventing symptomatic illness and 91.5% in protecting against asymptomatic infection.
The researchers found that vaccines are 97.2% effective against COVID-19-related hospitalization. They stressed that vaccine benefits are felt across all ages, writing: “In all age groups, as vaccine coverage increased, the incidence of SARS-CoV-2 outcomes declined.”
Using the full name for Pfizer’s vaccine, they stated: “Two doses of BNT162b2 are highly effective across all age groups in preventing symptomatic and asymptomatic SARS-CoV-2 infections and COVID-19-related hospitalizations, severe disease and death, including those caused by the [British] variant.
Tel Aviv University professor Jonathan Gershoni (courtesy) ....

Michael Edelstein , Jonathan Gershoni , Sharon Alroy Preis , Israel Health Ministry , Drug Administration , Bar Ilan University , Tel Aviv University , Ilan University , Health Ministry , Aviv University , மைக்கேல் எடெல்ஸ்டீன் , ஷரோன் அல்ராய் ப்ரேச் , இஸ்ரேல் ஆரோக்கியம் அமைச்சகம் , மதுக்கூடம் இலன் பல்கலைக்கழகம் , தொலைபேசி அவிவ் பல்கலைக்கழகம் , இலன் பல்கலைக்கழகம் , ஆரோக்கியம் அமைச்சகம் , அவிவ் பல்கலைக்கழகம் ,